Anti-muscarinic treatment
Showing 1 - 25 of >10,000
Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)
Recruiting
- Sjogren's Syndrome
- Overactive Bladder Syndrome
- mirabegron
- oxybutynin, tolterodine, solifenacin
-
Taichung, TaiwanChina Medical University Hospital
Aug 8, 2021
Pulmonary Disease, Chronic Obstructive Trial in New Zealand, Thailand, United Kingdom (400 microgrammes GSK961081, 1200
Completed
- Pulmonary Disease, Chronic Obstructive
- 400 microgrammes GSK961081
- 1200 microgrammes GSK961081
-
Wellington, New Zealand
- +3 more
Sep 28, 2021
Asthma Trial (Glycopyrronium bromide 25ug, Placebo, Glycopyrronium bromide 12.5ug)
Recruiting
- Asthma
- Glycopyrronium bromide 25ug
- +2 more
-
Ruse, Bulgaria
- +11 more
Jan 23, 2023
Urinary Bladder, Overactive Trial in Denizli (Transcutaneous tibial nerve stimulation (TTNS))
Not yet recruiting
- Urinary Bladder, Overactive
- Transcutaneous tibial nerve stimulation (TTNS)
-
Denizli, TurkeyPamukkale University
Dec 19, 2022
Urinary Bladder, Overactive Trial (intravaginal electrical stimulation added to bladder training)
Recruiting
- Urinary Bladder, Overactive
- intravaginal electrical stimulation added to bladder training
-
Denizli, TurkeyPamukkale Univercity
Oct 31, 2022
COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as
Completed
- Chronic Obstructive Pulmonary Disease
- SAR440340
- +5 more
-
Los Angeles, California
- +82 more
Oct 28, 2022
COPD Trial in Groningen, Leeuwarden (Tiotropium Bromide)
Recruiting
- COPD
- Tiotropium Bromide
-
Groningen, Netherlands
- +1 more
Jul 19, 2022
Post-COVID-19 Syndrome, Post-COVID Syndrome, Post COVID-19 Condition Trial in Mainz (Immunoadsorption, Sham-apheresis)
Recruiting
- Post-COVID-19 Syndrome
- +2 more
- Immunoadsorption
- Sham-apheresis
-
Mainz, Rheinland-Pfalz, GermanyUNIVERSITÄTSMEDIZIN der Johannes Gutenberg-Universität Mainz I.
May 2, 2023
Penehyclidine, Postoperative Nausea and Vomiting, Bimaxillar Surgery Trial in Beijing (Single injection of penehyclidine,
Completed
- Penehyclidine
- +2 more
- Single injection of penehyclidine
- +2 more
-
Beijing, ChinaPeking Univeristy Hospital Stomatology
Sep 14, 2021
COPD, Lower Respiratory Disease Trial in New York (Cardio-Pulmonary Exercise Testing (CPET))
Completed
- Chronic Obstructive Pulmonary Disease
- Lower Respiratory Disease
- Cardio-Pulmonary Exercise Testing (CPET)
-
New York, New YorkNew York University School of Medicine
Jan 7, 2022
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Multiple Sclerosis Trial in London (PIPE-307)
Completed
- Multiple Sclerosis
-
London, United KingdomHammersmith Medicines Research
Oct 4, 2022
Schizophrenia Trial in Boston (CVL-231)
Recruiting
- Schizophrenia
-
Boston, MassachusettsMassachusetts General Hospital Translational and Clinical Resear
Jul 6, 2022
Pulmonary Disease, Chronic Obstructive Trial in London (GSK961081, GSK961081 matching )
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- GSK961081 matching placebo
-
London, United KingdomGSK Investigational Site
Sep 28, 2021
Traumatic Brain Injury Trial in Sao Paulo (Biperiden Lactate, Placebo)
Recruiting
- Traumatic Brain Injury
- Biperiden Lactate
- Placebo
-
Sao Paulo, BrazilFederal University of São Paulo
Jun 17, 2021
Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Recruiting
- Takayasu's Arteritis
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
A Retrospective rEal-life daTa Study to Assess exaceRbations and
Completed
- COPD
- COPD Exacerbation
-
Thessaloniki, GreecePapanikolaou Hospital of Thessaloniki
Sep 7, 2022
Myocardium; Injury, Myocardial Infarction, Myocardial Ischemia Trial in Rawalpindi (Colchicine, Placebo oral tablet)
Suspended
- Myocardium; Injury
- +2 more
- Colchicine
- Placebo oral tablet
-
Rawalpindi, PakistanRawalpindi Institute of Cardiology
Dec 9, 2021
Toxic Effect of Organophosphate and Carbamate Insecticides Trial in High Point (Atropine Sulfate Ophthalmic Solution, Atropine
Completed
- Toxic Effect of Organophosphate and Carbamate Insecticides
- Atropine Sulfate Ophthalmic Solution
- Atropine Sulphate Injection
-
High Point, North CarolinaHigh Point Clinical Trials Center
Jul 20, 2021
Asthma in Children Trial in Jacksonville (Tiotropium Bromide)
Not yet recruiting
- Asthma in Children
- Tiotropium Bromide
-
Jacksonville, FloridaNemours Specialty Care
Aug 3, 2021
Depression, Anxiety, Stress Trial in Abbottabad (Lemon Balm Supplement, Matched Placebo)
Recruiting
- Depression
- +3 more
- Lemon Balm Supplement
- Matched Placebo
-
Abbottābād, PakistanAyub Teaching Hospital
Jan 4, 2023
COPD Trial in Worldwide (Dupilumab SAR231893, Inhaled Corticosteroid, Inhaled Long-Acting Beta Agonist)
Active, not recruiting
- Chronic Obstructive Pulmonary Disease
- Dupilumab SAR231893
- +4 more
-
Andalusia, Alabama
- +286 more
May 11, 2022
Chronic Obstructive Pulmonary Disease (COPD) Participants
Recruiting
- Pulmonary Disease, Chronic Obstructive
- prospective observational cohort study
-
Hannover, Niedersachsen, GermanyGSK Investigational Site
Jun 20, 2022
Myopia Trial in Kowloon (0.01% atropine eye drops, ortho-k)
Completed
- Myopia
- 0.01% atropine eye drops
- ortho-k
-
Kowloon, Hong KongSchool of Optometry, The Hong Kong Polytechnic University
Aug 6, 2021